Cybin Lands Conditional Approval To Become The First Psychedelics Company on The NYSE

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF), a biotech company in the psychedelics space, announced on Thursday a conditional approval to list on the New York Stock Exchange.

“A tier 1 listing in the U.S. can open up avenues to new and potential institutional buying, increased retail buying, and help increase the overall visibility of the company,” Cybin CEO Doug Drysdale told .

The company’s over-the-counter shares will uplist into the NYSE American’s Small Cap Equity Market. Cybin shares listed on Canada’s NEO Exchange will remain …

Full story available on Benzinga.com

More Cybin Lands Conditional Approval To Become The First Psychedelics Company on The NYSE